Sign In
Buy ATXI
$0.300
+0.0300 (+11.11%)
At Close: Jun 22, 2026
Avenue Therapeutics, Inc. (ATXI) Stock Sinks As Market Gains: What You Should Know
09:50pm, Wednesday, 22'nd Jul 2020
Avenue Therapeutics, Inc. (ATXI) closed the most recent trading day at $10.40, moving -1.61% from the previous trading session.
Avenue Therapeutics Announces Publication of Phase 3 Bunionectomy Study Results
12:30pm, Tuesday, 21'st Jul 2020
NEW YORK, July 21, 2020 -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today.
Avenue Therapeutics, Inc. (ATXI) Dips More Than Broader Markets: What You Should Know
09:50pm, Thursday, 16'th Jul 2020
Avenue Therapeutics, Inc. (ATXI) closed the most recent trading day at $9.83, moving -0.91% from the previous trading session.
Avenue Therapeutics, Inc. (ATXI) Dips More Than Broader Markets: What You Should Know
09:50pm, Thursday, 09'th Jul 2020
Avenue Therapeutics, Inc. (ATXI) closed the most recent trading day at $9.75, moving -1.52% from the previous trading session.
Is Avenue Therapeutics (ATXI) Stock Outpacing Its Medical Peers This Year?
03:30pm, Thursday, 09'th Jul 2020
Is (ATXI) Outperforming Other Medical Stocks This Year?
Pacira (PCRX) Provides Preliminary Results for Second Quarter
03:50pm, Tuesday, 07'th Jul 2020
Pacira (PCRX) reports preliminary results for the second quarter of 2020. The company's product sales are hurt by the COVID-19 pandemic. The stock fell in pre-market trading.
Fortress Biotech Added to Russell 3000® Index
12:30pm, Monday, 29'th Jun 2020
Annual Russell indexes’ reconstitution captures the 4,000 largest U.S. stocks as of May 8, ranking them by total market capitalization. Membership in the U.S. all-cap Russell 3000® Index, which re
Veru (VERU) Soars: Stock Adds 6.9% in Session
12:44pm, Thursday, 25'th Jun 2020
Veru (VERU) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Avenue Therapeutics, Inc. (ATXI) Upgraded to Strong Buy: Here's What You Should Know
04:00pm, Wednesday, 24'th Jun 2020
Avenue Therapeutics, Inc. (ATXI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
New Strong Buy Stocks for June 24th
03:18pm, Wednesday, 24'th Jun 2020
New Strong Buy Stocks for June 24th
Avenue Therapeutics' Shares March Higher, Can It Continue?
02:38pm, Tuesday, 23'rd Jun 2020
As of late, it has definitely been a great time to be an investor in Avenue Therapeutics
Aclaris Gets FDA Nod to Start Investigator-led Coronavirus Study
02:12pm, Thursday, 18'th Jun 2020
Aclaris (ACRS) announces that it supports an IND application to evaluate its oral investigational MK2 inhibitor compound, ATI-450, in hospitalized patients with COVID-19.
NGM Biopharmaceuticals (NGM) Soars: Stock Adds 7.8% in Session
12:50pm, Thursday, 18'th Jun 2020
NGM Biopharmaceuticals (NGM) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
Is Avenue Therapeutics (ATXI) Outperforming Other Medical Stocks This Year?
03:30pm, Wednesday, 17'th Jun 2020
Is (ATXI) Outperforming Other Medical Stocks This Year?
